PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'GSK, Singapore, Singapore. Electronic address: philippe.x.buchy@gsk.com.\', \'Académie nationale de médecine, Paris, France. Electronic address: yvesbuisson@hotmail.com.\', \'GSK, Rio de Janeiro, Brazil. Electronic address: otavio.a.cintra@gsk.com.\', \'New South Wales Health Pathology - Institute of Clinical Pathology and Medical Research, Westmead Hospital, New South Wales, Australia. Electronic address: dominic.dwyer@sydney.edu.au.\', \'Consultant in Infectious Diseases, University of Queensland, Brisbane, Australia. Electronic address: theniss@uq.edu.au.\', \'Scientific Advisor & Emeritus director at Valladolid NIC (National Influenza Centre) Spain, School of Medicine, Avd Ramón y Cajal s/n 47005 Valladolid, Spain. Electronic address: lejarazu@gmail.com.\', \'European Society for Clinical Microbiology and Infectious Diseases, Basel, Switzerland; Department of Molecular Medicine, The University of Pavia, Pavia, Italy; Department of Clinical, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: eskild.petersen@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00752-910.1016/j.ijid.2021.09.045
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34563707
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all